Product Details
Product Name:
CPI1189 |
CAS No.:
183619-38-7 |
Purity:
99.68% |
Supply Ability:
10g |
Release date:
2024/11/19 |
Product Introduction
Bioactivity
Name | CPI1189 |
Description | CPI1189 (REN-1189) is a TNF-a release inhibitor potentially for the treatment of sciatica and postherpetic neuralgia. |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMSO : 50 mg/mL (213.4 mM)
|
Keywords | Inhibitor | Tumor Necrosis Factor Receptor | inhibit | TNF Receptor | TNFR | REN 1189 | REN1189 | CPI1189 |
Inhibitors Related | Cepharanthine | Acetylcysteine | Acefylline | Glucosamine | Thalidomide | Taurochenodeoxycholic Acid | Apremilast | Pomalidomide | Bergenin | Lenalidomide | Fisetin | Linalool |
Related Compound Libraries | NF-κB Signaling Compound Library | Bioactive Compound Library | Antioxidant Compound Library | Anti-Viral Compound Library | Drug Repurposing Compound Library | Inhibitor Library | Neuroprotective Compound Library | Immuno-Oncology Compound Library | Anti-Aging Compound Library | Bioactive Compounds Library Max |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
CAS:480439-73-4
$468.00 / 1mg
-
CAS:3155-43-9
$97.00 / 1mg
-
Recommended supplier
Product name |
Price |
|
Suppliers |
Update time |
|
$/ |
|
Anhui Ruihan Technology Co., Ltd
|
2023-08-21 |